Impact of Intrathoracic Intercostal Nerve Block: Pain Management Following Thoracoscopic Surgery

Impact of Intrathoracic Intercostal Nerve Block: Pain Management Following Thoracoscopic Surgery - Impact of Thoracoscopic Intercostal Nerve Block

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016003

Enrollment

100

Registered

2014-12-19

Start date

2013-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest diseases necessitating surgery

Interventions

Intercostal nerve block. Medicine: a doubling dilution of 0.75% ropivacaine in normal saline Block site: every port Injection quantity: 2ml per one intercostal nerve

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Complete video assisted thoracoscopic surgery

Exclusion criteria

Exclusion criteria: thoracotomy

Design outcomes

Primary

Measure	Time frame
acute pain	—

Secondary

Measure	Time frame
postoperative neuropathic pain	—

Countries

Japan

Contacts

Public ContactTakahiro Homma

Joestu General Hospital Division of thoracic surgery

hommat.tym@gmail.com025-524-3000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026